Bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus Interactions
There are 348 drugs known to interact with bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus, along with 1 disease interaction. Of the total drug interactions, 348 are moderate.
- View all 348 medications that may interact with bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus
- View bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus disease interactions (1)
Most frequently checked interactions
View interaction reports for bifidobacterium infantis / bifidobacterium lactis / streptococcus thermophilus and the medicines listed below.
- Acerola C (ascorbic acid)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aleve Back and Muscle Pain (naproxen)
- Allegra (fexofenadine)
- Allegra Allergy (fexofenadine)
- Aspir 81 (aspirin)
- Azo Urinary Pain Relief (phenazopyridine)
- Azo-Cranberry (cranberry)
- Claritin (loratadine)
- Emergen-C (multivitamin with minerals)
- Flonase (fluticasone nasal)
- Iron Sulfate (ferrous sulfate)
- Lexapro (escitalopram)
- Macrobid (nitrofurantoin)
- Melatonin Time Release (melatonin)
- MiraLAX (polyethylene glycol 3350)
- Paxlovid (nirmatrelvir / ritonavir)
- Prilosec OTC (omeprazole)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zinc (zinc sulfate)
- Zyrtec (cetirizine)
Bifidobacterium infantis/bifidobacterium lactis/streptococcus thermophilus disease interactions
There is 1 disease interaction with bifidobacterium infantis / bifidobacterium lactis / streptococcus thermophilus which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.